In a pivotal move, the US Food and Drug Administration said Monday that it is taking steps to remove the lengthy “black box” warning on many hormone treatments for women with menopause symptoms, a ...

The US Food and Drug Administration plans to make changes soon to the lengthy black box warning on many hormone replacement products for women with menopause symptoms, Commissioner Dr. Martin Makary ...

For the past decade, Dr. Heather Hirsch has tried to convince women that hormone therapy drugs are the best way to treat symptoms of menopause and perimenopause. But warning labels on estrogen have ...

BLOOM (TAMPA) – U.S. health officials are taking the first steps toward removing the long-standing black box warning on estrogen products prescribed to treat menopause symptoms — a move that could ...

The U.S. Food and Drug Administration (FDA) announced it is initiating the removal of "black box" warning labels from hormone replacement therapy (HRT) products used to ease menopause symptoms, a move ...

When obstetrician JoAnn Pinkerton spoke on a Food and Drug Administration panel recently, she didn't mince words. "Please stop harming women," she said. Pinkerton argues that the FDA's black box ...

Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, the Food and Drug Administration announced Monday. In the ...

The U.S. Food and Drug Administration (FDA) announced this week that it would no longer require "black box warnings"-the highest level of medication safety warnings-on prescription low-dose estrogen ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...

For more than 20 years, menopausal hormone therapy carried the U.S. Food and Drug Administration’s (FDA) most serious safety notice: a black box warning that linked treatment to increased risk of ...